Sec. 2. Allowing for more flexibility with respect to medication-assisted treatment for opioid use disorders
157 words·~1 min read·
/bill/115/hr/5807/ih/section-2·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Subclause
(II)of section 303(g)(2)(B)(iii) of the Controlled Substances Act ( 21 U.S.C. 823(g)(2)(B)(iii) ) is amended to read as follows: The applicable number is— 100 if, not sooner than 1 year after the date on which the practitioner submitted the initial notification, the practitioner submits a second notification to the Secretary of the need and intent of the practitioner to treat up to 100 patients; 100 if the practitioner holds additional credentialing, as defined in section 8.2 of title 42, Code of Federal Regulations (or successor regulations); or 100 if the practitioner provides medication-assisted treatment
(MAT)using covered medications (as defined in section 8.2 of title 42, Code of Federal Regulations (or successor regulations)) in a qualified practice setting (as described in section 8.615 of title 42, Code of Federal Regulations (or successor regulations)). . Section 303(g)(2)(G)(iii)(II) of the Controlled Substances Act ( 21 U.S.C. 823(g)(2)(G)(iii)(II) ) is amended by striking 2021 and inserting 2028 .
Connectionstraces to 1
Traces to 1 document
U.S. Code
Citation graph
cites case law
Sec. 2
Allowing for more flexibility with respect to medication-assisted treatment for opioid use disorders
Cites 1Cited by 0 across 0 sources